Efficacy and safety of Lianhuaqingwen for mild or moderate coronavirus disease 2019
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
General Medicine
Reference20 articles.
1. The use of an herbal formula by hospital care workers during the severe acute respiratory syndrome epidemic in Hong Kong to prevent severe acute respiratory syndrome transmission, relieve influenza-related symptoms, and improve quality of life: a prospective cohort study;Lau;J Altern Complement Med,2005
2. The lesson of supplementary treatment with Chinese medicine on severe laboratory-confirmed SARS patients;Hsu;Am J Chin Med,2006
3. Oseltamivir compared with the Chinese traditional therapy maxingshigan-yinqiaosan in the treatment of H1N1 influenza: a randomized trial;Wang;Ann Intern Med,2011
4. The Cochrane collaboration's tool for assessing risk of bias in randomized trials;Higgins;BMJ,2011
5. Observation on the Therapeutic effect of Lianhua Qingwen granule combined with Abidole in the treatment of mild COVID-19;Yu;Chinese Pharmaceutical Journal
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Mechanism of Lian Hua Qing Wen capsules regulates the inflammatory response caused by M1 macrophage based on cellular experiments and computer simulations;Acta Tropica;2024-09
2. Effects of Lianhuaqingwen Capsules in adults with mild-to-moderate coronavirus disease 2019: an international, multicenter, double-blind, randomized controlled trial;Virology Journal;2023-11-28
3. Intestinal Escherichia coli and related dysfunction as potential targets of Traditional Chinese Medicine for respiratory infectious diseases;Journal of Ethnopharmacology;2023-09
4. Combination of Chinese herbal medicine and conventional western medicine for coronavirus disease 2019: a systematic review and meta-analysis;Frontiers in Medicine;2023-07-17
5. Traditional Chinese medicine treatment for COVID-19: An overview of systematic reviews and meta-analyses;Journal of Integrative Medicine;2022-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3